메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
조세경 (연세대학교 의과대학 세브란스병원 약무국) 정민재 (연세대학교의료원 세브란스병원 약무국) 김재송 (연세대학교) 손은선 (연세대학교) 유윤미 (연세대학교 약학대학)
저널정보
한국병원약사회 병원약사회지 병원약사회지 제37권 제3호
발행연도
2020.1
수록면
292 - 304 (13page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Background : Currently, most clinical trials are conducted on adults. Also, dose formulations are developed based on adult standard doses, resulting in problems with pediatric administration. Firstly, the excess drugs become medical waste. Secondly, patients may be overcharged even when they only use a small portion of the drugs. Lastly, medical errors may arise while preparing and administering pediatric doses with comparatively large dose formulations. Therefore, this study aimed to analyze the status of injectable drug use in pediatric inpatients and estimate the discarded drug amounts and the proportion of the actual dose used, thus evaluating the marketability of lower dose formulations. Methods : The data of injectable drugs prescribed from June 1, 2018, to May 31, 2019, were collected and retrospectively analyzed using the Order Communication System program. Results : The average daily injectable drug prescriptions for children were 1,738.1, and 40.1% of them were for less than the dose formulations. The number of injections discarded daily was 435.7, accounting for 1,692,217 Korean won. The injectable drugs frequently prescribed in small proportions were dexamethasone 5 mg/ampoule (A), ranitidine 50 mg/A, cimetidine 200 mg/A, and furosemide 20 mg/A. Among the top 20 products, only seven had lower dose formulations available in Korea, of which three were unavailable due to low demand, never produced though granted permission, and one was due to non reimbursement by insurance. Moneywise, the biggest loss was from caspofungin 50 mg/vial (V), whose daily drug disposal accounted for 256,352 Korean won, followed by smoflipid 20%® 100 ml/bottle, ganciclovir 500 mg/V, and teicoplanin 200 mg/V. Conclusion : This study showed that utilizing injectable drugs with adult dose formulations for children could result in biohazardous medical waste and economic losses. However, there are only a few alternatives currently available. Therefore, the government, instead of individual medical institutions or pharmaceutical companies, should authorize the investigation and development of lower dose formulations for children.

목차

등록된 정보가 없습니다.

참고문헌 (17)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0